PortfoliosLab logoPortfoliosLab logo
CB vs. MEDP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CB vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Chubb Limited (CB) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CB achieves a 3.43% return, which is significantly higher than MEDP's -18.47% return.


CB

1D
-1.35%
1M
0.70%
YTD
3.43%
6M
8.96%
1Y
10.97%
3Y*
20.64%
5Y*
15.72%
10Y*
11.89%

MEDP

1D
0.80%
1M
8.00%
YTD
-18.47%
6M
-16.62%
1Y
54.44%
3Y*
30.12%
5Y*
21.82%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CB vs. MEDP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CB
Chubb Limited
3.43%14.46%23.89%4.20%15.97%27.85%1.41%22.94%-9.63%12.82%
MEDP
Medpace Holdings, Inc.
-18.47%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%

Correlation

The correlation between CB and MEDP is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Aug 12, 2016

0.18

The correlation between CB and MEDP shifts across timeframes, from -0.05 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CB:

$127.01B

MEDP:

$13.26B

EPS

CB:

$28.35

MEDP:

$15.63

PE Ratio

CB:

11.35

MEDP:

29.29

PEG Ratio

CB:

0.79

MEDP:

0.88

PS Ratio

CB:

2.67

MEDP:

5.04

PB Ratio

CB:

1.59

MEDP:

22.17

Total Revenue (TTM)

CB:

$48.15B

MEDP:

$2.68B

Gross Profit (TTM)

CB:

$17.01B

MEDP:

$778.59M

EBITDA (TTM)

CB:

$12.22B

MEDP:

$572.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CB vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CB
CB Risk / Return Rank: 6161
Overall Rank
CB Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
CB Sortino Ratio Rank: 5555
Sortino Ratio Rank
CB Omega Ratio Rank: 5454
Omega Ratio Rank
CB Calmar Ratio Rank: 6565
Calmar Ratio Rank
CB Martin Ratio Rank: 6666
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 7373
Overall Rank
MEDP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7373
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7070
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CB vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Chubb Limited (CB) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CBMEDPDifference
Sharpe ratioReturn per unit of total volatility

-0.17

Sortino ratioReturn per unit of downside risk

-0.83

Omega ratioGain probability vs. loss probability

1.12

1.32

-0.19

Calmar ratioReturn relative to maximum drawdown

1.18

1.49

-0.32

Martin ratioReturn relative to average drawdown

2.70

3.38

-0.68

CB vs. MEDP - Sharpe Ratio Comparison

The current CB Sharpe Ratio is 0.62, which is comparable to the MEDP Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of CB and MEDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CBMEDPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.62

0.79

-0.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.78

0.43

+0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

0.40

0.67

-0.27

Drawdowns

CB vs. MEDP - Drawdown Comparison

The maximum CB drawdown since its inception was -50.99%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for CB and MEDP.


Loading charts...

Drawdown Indicators


CBMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-50.99%

-42.87%

-8.12%

Max Drawdown (1Y)

Largest decline over 1 year

-9.36%

-36.61%

+27.25%

Max Drawdown (3Y)

Largest decline over 3 years

-14.35%

-39.38%

+25.03%

Max Drawdown (5Y)

Largest decline over 5 years

-19.26%

-42.87%

+23.61%

Max Drawdown (10Y)

Largest decline over 10 years

-42.59%

Current Drawdown

Current decline from peak

-5.81%

-26.22%

+20.41%

Average Drawdown

Average peak-to-trough decline

-10.68%

-12.91%

+2.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.52%

16.16%

-11.64%

Volatility

CB vs. MEDP - Volatility Comparison

The current volatility for Chubb Limited (CB) is 6.11%, while Medpace Holdings, Inc. (MEDP) has a volatility of 6.61%. This indicates that CB experiences smaller price fluctuations and is considered to be less risky than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CBMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.11%

6.61%

-0.50%

Volatility (6M)

Calculated over the trailing 6-month period

13.14%

37.78%

-24.64%

Volatility (1Y)

Calculated over the trailing 1-year period

17.69%

69.11%

-51.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.34%

51.61%

-31.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.69%

49.80%

-26.11%

Dividends

CB vs. MEDP - Dividend Comparison

CB's dividend yield for the trailing twelve months is around 1.21%, while MEDP has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CB
Chubb Limited
1.21%1.22%1.30%1.51%1.49%1.65%2.01%1.91%2.24%1.93%2.07%4.23%
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

CB vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Chubb Limited and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
1.88B
706.60M
(CB) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CB and MEDP have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MEDP has higher volatility (6.61%) compared to CB (6.11%). In terms of maximum drawdown, CB dropped -50.99% vs MEDP's -42.87%.

MEDP currently has the higher Sharpe Ratio (0.79 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CB and MEDP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer